{
    "paper_id": "025694dc05686319c2b00e46947ef8d00d4ac769",
    "metadata": {
        "title": "",
        "authors": [
            {
                "first": "Jos\u00e9",
                "middle": [],
                "last": "Manuel Gonz\u00e1lez-Rayas",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Monterrey Institute of Technology and Higher Education",
                    "location": {
                        "settlement": "Monterrey",
                        "country": "M\u00e9xico"
                    }
                },
                "email": ""
            },
            {
                "first": "Ana",
                "middle": [],
                "last": "Lilia",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Rayas-G\u00f3mez",
                "middle": [],
                "last": "Jos\u00e9",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Juan",
                "middle": [],
                "last": "Garc\u00eda-Gonz\u00e1lez",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Hospital San Jos\u00e9 de Quer\u00e9taro",
                    "location": {
                        "settlement": "Quer\u00e9taro",
                        "country": "M\u00e9xico"
                    }
                },
                "email": ""
            },
            {
                "first": "Jos\u00e9",
                "middle": [],
                "last": "Manuel Gonz\u00e1lez-Y\u00e1\u00f1ez",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Hospital San Jos\u00e9 de Quer\u00e9taro",
                    "location": {
                        "settlement": "Quer\u00e9taro",
                        "country": "M\u00e9xico"
                    }
                },
                "email": ""
            },
            {
                "first": "Jos\u00e9",
                "middle": [],
                "last": "Ascenci\u00f3n Hern\u00e1ndez-Hern\u00e1ndez",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Cancer Research. Monterrey Institute of Technology and Higher Education",
                    "location": {
                        "settlement": "Monterrey",
                        "country": "M\u00e9xico"
                    }
                },
                "email": ""
            },
            {
                "first": "Rosa",
                "middle": [],
                "last": "Del Carmen L\u00f3pez-S\u00e1nchez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Manuel",
                "middle": [],
                "last": "Gonz\u00e1lez-Rayas",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "J",
                "middle": [],
                "last": "",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Rayas-G\u00f3mez",
                "middle": [],
                "last": "Al",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Manuel",
                "middle": [],
                "last": "Gonz\u00e1lez-Y\u00e1\u00f1ez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ascenci\u00f3n",
                "middle": [],
                "last": "Hern\u00e1ndez-Hern\u00e1ndez",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Ana",
                "middle": [
                    "Lilia"
                ],
                "last": "Rayas-G\u00f3mez",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Hospital San Jos\u00e9 de Quer\u00e9taro",
                    "location": {
                        "settlement": "Quer\u00e9taro",
                        "country": "M\u00e9xico"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "J o u r n a l P r e -p r o o f distributed globally and has become the focus of extensive medical research, as the number of cases keeps rising. A significant part of the investigative effort has been directed to the search for an effective therapy or intervention that could stop the spread of the disease or be used to effectively treat infected patients. Likewise, potential predisposing factors to develop a more severe clinical presentation are progressively being identified.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Some of the more relevant are older age and the presence of certain comorbidities, such as cerebrovascular and coronary heart disease, hypertension and diabetes [5] [6] [7] [8] .",
            "cite_spans": [
                {
                    "start": 161,
                    "end": 164,
                    "text": "[5]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 165,
                    "end": 168,
                    "text": "[6]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 169,
                    "end": 172,
                    "text": "[7]",
                    "ref_id": null
                },
                {
                    "start": 173,
                    "end": 176,
                    "text": "[8]",
                    "ref_id": "BIBREF10"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "It is important to highlight that the last two are chronic conditions commonly treated with ACE-inhibitors and angiotensin II type-I receptor blockers [9] [10] [11] . However, the evidence suggests that these medications can upregulate the expression of angiotensin converting enzyme 2 (ACE2), the cellular receptor for both SARS-CoV and SARS-CoV-2 [11] [12] [13] [14] [15] [16] . Thus, a group of researchers hypothesized that ACE2increasing drugs could raise the risk of infection and prompt a more severe clinical course or a fatal outcome in diabetic and hypertensive patients 11 .",
            "cite_spans": [
                {
                    "start": 151,
                    "end": 154,
                    "text": "[9]",
                    "ref_id": null
                },
                {
                    "start": 155,
                    "end": 159,
                    "text": "[10]",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 160,
                    "end": 164,
                    "text": "[11]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 349,
                    "end": 353,
                    "text": "[11]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 354,
                    "end": 358,
                    "text": "[12]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 359,
                    "end": 363,
                    "text": "[13]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 364,
                    "end": 368,
                    "text": "[14]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 369,
                    "end": 373,
                    "text": "[15]",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 374,
                    "end": 378,
                    "text": "[16]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "As a result, the safety of ACE-inhibitors and angiotensin receptor blockers in COVID-19 patients was put into question and an intense debate arose.",
            "cite_spans": [],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Nonetheless, although the idea of the intensification of ACE2 receptor expression, leading to an increased risk of COVID-19 infection is reasonable, hypertension and diabetes are also frequent comorbidities of MERS-CoV 17 . The latter is relevant since MERS-CoV uses a distinct host-cell receptor, namely the dipeptidyl peptidase 4 (DPP4), also known as CD26. Hence, it would seem that the relation between chronic conditions and SARS-CoV-2 could be explained by the general Furthermore, we suggest that SARS-CoV-2 infection should not just be considered as a single but as a dual phase phenomenon. Therefore, in the first phase of SARS-CoV-2 infection, expressing a higher number of ACE2 receptors could indeed promote viral entry 11 . However, in a second or a later phase of the infection, ACE2 receptors may be protective of SARS-CoV-2 mediated acute lung injury 18, 19 .",
            "cite_spans": [
                {
                    "start": 867,
                    "end": 870,
                    "text": "18,",
                    "ref_id": "BIBREF22"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "In fact, experimental evidence shows that SARS-CoV infection is paired with a decrease in the expression of ACE2 [18] [19] [20] . As a consequence, the physiological antagonism of ACE2 over the classical renin-angiotensin-aldosterone system (RAAS) is blunted. In normal circumstances, the vasoconstrictor peptide angiotensin II is metabolized by ACE2 to produce angiotensin 1-7 (Ang 1-7) 18 . Ang 1-7 is then able to interact with Mas, a G-protein-coupled receptor with known vasoprotective effects 18, 19, 21, 22 . Moreover, Ang 1-7 has been shown to reduce inflammation, tissue damage and lung edema in the set of acute respiratory distress syndrome 23 . This suggests that along with the viral load and the host immune response to SARS-CoV-2, an over-active RAAS could contribute to the exacerbated lung injury generated by COVID-19. Thus, recombinant ACE2 may be an effective therapeutic approach to treat COVID-19 cases, as some studies already suggest 24 . Additionally, cyclic Ang 1-7, which shows increased resistance to human peptidases, such as angiotensin-converting enzyme (ACE) and dipeptidyl peptidase 3 (DPP3), could counteract the downregulation of ACE2 caused by SARS-CoV-2 infection 25, 26 .",
            "cite_spans": [
                {
                    "start": 113,
                    "end": 117,
                    "text": "[18]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 118,
                    "end": 122,
                    "text": "[19]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 123,
                    "end": 127,
                    "text": "[20]",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 499,
                    "end": 502,
                    "text": "18,",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 503,
                    "end": 506,
                    "text": "19,",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 507,
                    "end": 510,
                    "text": "21,",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 511,
                    "end": 513,
                    "text": "22",
                    "ref_id": null
                },
                {
                    "start": 958,
                    "end": 960,
                    "text": "24",
                    "ref_id": null
                },
                {
                    "start": 1201,
                    "end": 1204,
                    "text": "25,",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 1205,
                    "end": 1207,
                    "text": "26",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Finally, it is important to mention that the protease (Ang 1-7 generation) and the SARS-CoV receptor functions of ACE2 are independent 18 . In consequence, catalytically inactive ACE2 receptors can still interact with viral particles. Moreover, ACE2 is still active while the SARS spike proteins is bound 18, 27 . This is important, since it opens the possibility for the development of selective drugs that specifically target the ACE2 domain used by the SARS-CoV-2 to enter the host-cell without affecting the production of Ang 1-7. Nonetheless, intensive experimental and clinical research should validate the feasibility of this approach.",
            "cite_spans": [
                {
                    "start": 305,
                    "end": 308,
                    "text": "18,",
                    "ref_id": "BIBREF22"
                }
            ],
            "ref_spans": [],
            "section": "J o u r n a l P r e -p r o o f"
        },
        {
            "text": "The authors report no conflicts of interest.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conflicts of interest"
        },
        {
            "text": "None.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Funding"
        },
        {
            "text": "None. ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Acknowledgements"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Pathogenicity and transmissibility of 2019-nCoV-A quick overview and comparison with other emerging viruses. Microbes and Infection",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "22",
            "issn": "",
            "pages": "69--71",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Another Decade, Another Coronavirus",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "8",
            "pages": "760--762",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Disease Briefing: Coronaviruses",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Cortellis",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "COVID-19: possible accelerated progression to a fatal outcome for elder patients",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Gonz\u00e1lez-Rayas",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Open Science Framework",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study. The Lancet Respiratory Medicine",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Coronavirus Disease 2019 in China",
            "authors": [],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "China. Allergy",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials",
            "authors": [
                {
                    "first": "Angiotensin-Converting Enzyme",
                    "middle": [],
                    "last": "Inhibitors",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Am J Hypertension",
            "volume": "24",
            "issn": "5",
            "pages": "582--90",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Benefits of ACE Inhibitors in Diabetes",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "E"
                    ],
                    "last": "Ramos-Nino",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Blumen",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet Respiratory Medicine",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Fang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Karakiulakis",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Roth",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "ACE2: A New Target for Prevention of Diabetic Nephropathy?: Figure 1",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Ingelfinger",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "JASN",
            "volume": "17",
            "issn": "11",
            "pages": "2957--2966",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Tikellis",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Thomas",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "International Journal of Peptides",
            "volume": "2012",
            "issn": "",
            "pages": "1--8",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Ferrario",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Jessup",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Chappell",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "B"
                    ],
                    "last": "Averill",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "B"
                    ],
                    "last": "Brosnihan",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Tallant",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Circulation",
            "volume": "111",
            "issn": "20",
            "pages": "2605--2615",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Meng",
                    "suffix": ""
                },
                {
                    "first": "Xiao",
                    "middle": [
                        "B"
                    ],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Ying",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Clinical and Experimental Pharmacology and Physiology",
            "volume": "37",
            "issn": "1",
            "pages": "1--6",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Alrasheed",
                    "middle": [],
                    "last": "Mm",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Epidemiol Infect",
            "volume": "147",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kuba",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Imai",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ohto-Nakanishi",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Penninger",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Pharmacology & Therapeutics",
            "volume": "128",
            "issn": "1",
            "pages": "119--147",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Viral Pathogens and Acute Lung Injury: Investigations Inspired by the SARS Epidemic and the 2009 H1N1 Influenza Pandemic. Semin Respir Crit Care Med",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hendrickson",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Matthay",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "",
            "volume": "34",
            "issn": "",
            "pages": "475--86",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kuba",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Imai",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rao",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nat Med",
            "volume": "11",
            "issn": "8",
            "pages": "875--884",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "G-proteins coupled receptors",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "N\u00e1jera",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "P"
                    ],
                    "last": "Mart\u00ednez-Vega",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Portilla-Mart\u00ednez",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Ortiz-Vilchis",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Ceballos",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Cardiovascular and Metabolic Science",
            "volume": "30",
            "issn": "2",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Mas receptor axis in inflammation and fibrosis: Angiotensin-(1-7) in inflammation and fibrosis",
            "authors": [],
            "year": 2013,
            "venue": "Br J Pharmacol",
            "volume": "169",
            "issn": "3",
            "pages": "477--92",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Acute respiratory distress syndrome leads to reduced ratio of ACE/ACE2 activities and is prevented by angiotensin-(1-7) or an angiotensin II receptor antagonist",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "W\u00f6sten-Van Asperen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lutter",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Specht",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "N"
                    ],
                    "last": "Moll",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "B"
                    ],
                    "last": "Van Woensel",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Van Der Loos",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Pathol",
            "volume": "225",
            "issn": "4",
            "pages": "618--645",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Inhibition of SARS-CoV-2 infections in engineered human tissues using clinicalgrade soluble human ACE2",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "29",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Cassis",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Locatelli",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Corna",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Villa",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Rottoli",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cerullo",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Kidney International",
            "volume": "96",
            "issn": "4",
            "pages": "906--923",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Stabilization of Angiotensin-(1-7) by key substitution with a cyclic non-natural amino acid",
            "authors": [],
            "year": 2017,
            "venue": "Amino Acids",
            "volume": "49",
            "issn": "10",
            "pages": "1733--1775",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Farzan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Harrison",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Science",
            "volume": "309",
            "issn": "5742",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF1": {
            "text": "Renin angiotensin system (RAAS) overactivation as a result of SARS-CoV-2 infection. In physiological conditions, the angiotensin converting enzyme (ACE) metabolizes angiotensin I (Ang I) to angiotensin II (Ang II), thus leading to increased vasoconstriction, inflammation, fibrosis, lung damage and edema. Conversely, angiotensin converting enzyme 2 (ACE 2) inactivates Ang I by generating angiotensin 1-7 (Ang 1-7), which then interacts with the G-proteincoupled receptor Mas. This interaction is known to be vasoprotective, since it antagonizes the actions of Ang I. However, SARS-CoV-2 downregulates the expression of ACE2, thus leading to RAAS overactivation and to increased lung damage and edema. Created with BioRender.com.",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": []
}